Skip to main content

GES

Genesis Resources (ASX: GES) is still waiting for assay results. Their AGM presentation was not overly optimistic about anything. A good result at Alice Springs will deliver a short-term boost, and those results are pending, although I doubt that they had the spare cash to put a "hurry-up" on the results. So I reckon the price will stay low for a little while and then the assay results will push it up quickly. I will check back in a couple of weeks to see if it is still low as it may give me a buying opportunity.

Comments

Post a Comment

Popular posts from this blog

BOT

 As far as quarterly announcements go, the one out today from BOT is one of the nest I have ever seen. And it only get beaten by the next quarterly. The only way this stock is going is up - with the potential of a takeover offer (nothing is certain).
Post a Comment
Read more

It's 31 Jan

 And that means we will hear about the AAR T/O offer of MXR today or tomorrow. Considering that MXR have not been sitting idle while AAR have been going through the data, I would like to think that the offer will be increased. Already the offer is at 7 cents (AAR scrip equivalent) in a share swap - no you don't get the cash, you get the shares in AAR. As I wrwite this, MXR is still at 6.3 cents, so there could be a quick profit to be made for those who can jump fast.
Post a Comment
Read more

A Couple of Updates

 Well, it's Monday morning and the week has started with a bang. First, PFE announced that there was an unexpected problem with their test drill and they have had to abandon that and go to a new test drill site. A delay, but no real issue apart from that. And the market hated that. Good news for those wanting to buy, not so good for existing holders. IMC released their AGM presentation which indicates that there will be some news in December and then a very busy (and hopefully productive) 2025. Sales are good and continuing to get better and better.
Post a Comment
Read more